$KARX
Karbon-X Corp.

2023 Q1 Form 10-Q Financial Statement

#000147793223000473 Filed on January 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4
Revenue $7.823K $0.00
YoY Change
Cost Of Revenue $1.190K $0.00
YoY Change
Gross Profit $6.634K $0.00
YoY Change
Gross Profit Margin 84.8%
Selling, General & Admin $249.0K $112.3K
YoY Change 354.88%
% of Gross Profit 3752.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $290.00 $300.00
YoY Change
% of Gross Profit 4.37%
Operating Expenses $391.9K $142.4K
YoY Change 20913.3% 476.81%
Operating Profit -$385.3K -$142.4K
YoY Change 20557.64%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $13.48K $493.00
YoY Change -102.0%
Pretax Income -$371.8K -$141.9K
YoY Change 19781.76% 474.82%
Income Tax
% Of Pretax Income
Net Earnings -$371.8K -$141.9K
YoY Change 19781.76% 474.77%
Net Earnings / Revenue -4752.51%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 69.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $102.2K $57.42K
YoY Change 72907.14% 44069.23%
Cash & Equivalents $102.2K $57.42K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses $0.00 $0.00
Receivables $1.860K
Other Receivables $24.18K
Total Short-Term Assets $134.2K $83.46K
YoY Change 95043.26% 62182.84%
LONG-TERM ASSETS
Property, Plant & Equipment $5.507K $5.773K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.138M $1.125M
YoY Change
Other Assets $90.38K $83.51K
YoY Change
Total Long-Term Assets $1.838M $1.567M
YoY Change -39174850.0%
TOTAL ASSETS
Total Short-Term Assets $134.2K $83.46K
Total Long-Term Assets $1.838M $1.567M
Total Assets $1.973M $1.650M
YoY Change 1398842.55% 1269476.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.66K $72.75K
YoY Change 21199.62% 770.26%
Accrued Expenses $3.150K $4.600K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $99.60K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $174.3K $77.34K
YoY Change 64448.15% -21.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $174.3K $77.34K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $174.3K $77.34K
YoY Change 65416.92% -21.32%
SHAREHOLDERS EQUITY
Retained Earnings -$850.3K -$542.0K
YoY Change 320753.58% 363.03%
Common Stock $70.04K $69.04K
YoY Change 7.92% 6.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.798M $1.573M
YoY Change
Total Liabilities & Shareholders Equity $1.973M $1.650M
YoY Change 1398842.55% 1231578.36%

Cashflow Statement

Concept 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$371.8K -$141.9K
YoY Change 19781.76% 474.77%
Depreciation, Depletion And Amortization $290.00 $300.00
YoY Change
Cash From Operating Activities -$484.1K $68.66K
YoY Change -134586.11% -36236.84%
INVESTING ACTIVITIES
Capital Expenditures $104.0K $176.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$104.0K -$176.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 599.6K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -484.1K 68.66K
Cash From Investing Activities -104.0K -176.0K
Cash From Financing Activities 599.6K 0.000
Net Change In Cash 11.45K -107.3K
YoY Change 3080.56% 56384.21%
FREE CASH FLOW
Cash From Operating Activities -$484.1K $68.66K
Capital Expenditures $104.0K $176.0K
Free Cash Flow -$588.1K -$107.3K
YoY Change -163475.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
477339 usd
karx Weighted Average Remaining Contractual Life In Years Granted
WeightedAverageRemainingContractualLifeInYearsGranted
P1Y6M
karx Weighted Average Remaining Contractual Life In Years Ending Balance
WeightedAverageRemainingContractualLifeInYearsEndingBalance
P1Y4M13D
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Central Index Key
EntityCentralIndexKey
0001729637
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73540000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68320000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-11-30
dei Entity File Number
EntityFileNumber
000-56288
dei Entity Registrant Name
EntityRegistrantName
KARBON-X CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-2882342
dei Entity Address Address Line1
EntityAddressAddressLine1
1410 Columbia Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
Castlegar
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
N1N 3K3
dei City Area Code
CityAreaCode
778
dei Local Phone Number
LocalPhoneNumber
256-5730
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69040000 shares
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
57420 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2022Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
10809 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2808 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
490957 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3254 usd
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
352948 usd
CY2022Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
176777 usd
CY2022Q4 karx Inventory
Inventory
82210 usd
CY2022Q2 karx Inventory
Inventory
0 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4597 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2976 usd
CY2022Q4 us-gaap Liabilities
Liabilities
77342 usd
CY2022Q2 us-gaap Liabilities
Liabilities
33730 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68320000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
69040 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
68320 usd
CY2022Q4 karx Shares To Be Issued
SharesToBeIssued
1125000 usd
CY2022Q2 karx Shares To Be Issued
SharesToBeIssued
0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
966102 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
786822 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-542018 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-204228 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45017 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13044 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1573107 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
637870 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1650449 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
671600 usd
CY2022Q4 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q4 us-gaap Marketing Expense
MarketingExpense
8320 usd
us-gaap Marketing Expense
MarketingExpense
18984 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
70277 usd
us-gaap Professional Fees
ProfessionalFees
156872 usd
CY2022Q4 us-gaap Other General Expense
OtherGeneralExpense
63818 usd
us-gaap Other General Expense
OtherGeneralExpense
162427 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
142415 usd
us-gaap Operating Expenses
OperatingExpenses
338283 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-142415 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-338283 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
493 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
493 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-141922 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-337790 usd
CY2022Q4 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-141922 usd
us-gaap Net Income Loss
NetIncomeLoss
-337790 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-21755 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-31973 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-163677 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-369763 usd
CY2022Q4 karx Weighted Average Basic And Diluted Shares Outstanding
WeightedAverageBasicAndDilutedSharesOutstanding
69840000 shares
karx Weighted Average Basic And Diluted Shares Outstanding
WeightedAverageBasicAndDilutedSharesOutstanding
69356923 shares
CY2022Q4 karx Earnings Per Share Basic And Fully Diluted
EarningsPerShareBasicAndFullyDiluted
-0.00
karx Earnings Per Share Basic And Fully Diluted
EarningsPerShareBasicAndFullyDiluted
-0.00
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
611784 usd
CY2022Q4 karx Shares To Be Issue For Investment
SharesToBeIssueForInvestment
1125000 usd
CY2022Q4 karx Translation Gain Loss
TranslationGainLoss
-21755 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-141922 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1573107 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
637870 usd
karx Shares To Be Issued For Investment
SharesToBeIssuedForInvestment
1125000 usd
karx Issuance Of Shares And Warrants For Cash Amount
IssuanceOfSharesAndWarrantsForCashAmount
180000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-31973 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1573107 usd
us-gaap Net Income Loss
NetIncomeLoss
-337790 usd
us-gaap Depreciation
Depreciation
528 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
245 usd
us-gaap Accounts Receivable Sale
AccountsReceivableSale
1862 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-13368 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
41991 usd
us-gaap Increase Decrease In Trading Liabilities
IncreaseDecreaseInTradingLiabilities
1620 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
82209 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2808 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-692 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-388729 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3046 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
176171 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-179217 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
180000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
180000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-31973 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-419919 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477339 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57420 usd
karx Shares To Be Issued For The Silviculture Investment
SharesToBeIssuedForTheSilvicultureInvestment
1125000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
karx Issued And Outstanding Shares Of Common Stock Converted Exchange Ratio Description
IssuedAndOutstandingSharesOfCommonStockConvertedExchangeRatioDescription
20,000-for-1
CY2022Q4 karx Shares Authorized
SharesAuthorized
20000000 shares
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
134 usd
CY2022Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
99902 usd
karx Going Concern Policy Textblock
GoingConcernPolicyTextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To date the Company has generated no revenues from its business operations and has incurred operating losses since inception of $542,018.  The Company will require additional funding to meet its ongoing obligations and to fund anticipated operating losses.  The ability of the Company to continue as a going concern is dependent on raising capital to fund its initial business plan and ultimately to attain profitable operations.  Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern.  The Company intends to continue to fund its business by way of private placements and advances from related parties as may be required. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.</p>
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-542018 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4140000 shares
CY2022Q4 karx Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice
0.75
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. </p>
CY2022Q4 karx Prepaid Accounting Services Current
PrepaidAccountingServicesCurrent
0 usd
CY2022Q2 karx Prepaid Accounting Services Current
PrepaidAccountingServicesCurrent
2544 usd
CY2022Q4 karx Prepaid Furniture Expenses Current
PrepaidFurnitureExpensesCurrent
0 usd
CY2022Q2 karx Prepaid Furniture Expenses Current
PrepaidFurnitureExpensesCurrent
264 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2808 usd
CY2022Q4 karx Carbon Credit Inventory Amount
CarbonCreditInventoryAmount
82209 usd
CY2022Q2 karx Carbon Credit Inventory Amount
CarbonCreditInventoryAmount
0 usd
CY2022Q4 us-gaap Other Inventory
OtherInventory
82209 usd
CY2022Q2 us-gaap Other Inventory
OtherInventory
0 usd
CY2022Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1710 usd
CY2022Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1529 usd
us-gaap Depreciation
Depreciation
528 usd
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
720000 shares
karx Stock Option Exercise Price
StockOptionExercisePrice
0.25
karx Proceeds From Issuance Of Private Placement1
ProceedsFromIssuanceOfPrivatePlacement1
180000 usd
karx Share Of Common Stock In Warrant Desription
ShareOfCommonStockInWarrantDesription
Each unit consisted of share of common stock and warrant to purchase a share of common stock for $0.75 per share for a period of two years.
karx Statement Of Stockholders Equity
StatementOfStockholdersEquity
the purchase of up to 80% of Silviculture Systems to be issued in tranches based on completion of milestones. As of November 30, 2022, the Company has purchased 24% of Silviculture Systems for 4,500,000 shares of Karbon-X Corp shown as shares to be issued for a value of $1,125,000
CY2022Q4 karx Warrants Issued
WarrantsIssued
720000 shares
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.75
karx Value Of Warrants
ValueOfWarrants
180000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3420000 shares
CY2022Q2 karx Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice
0.75
karx Weighted Average Remaining Contractual Life In Years Beginning Balance
WeightedAverageRemainingContractualLifeInYearsBeginningBalance
P1Y3M29D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
720000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.75
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
karx Share Based Compensation Arrangements By Share Based Payment Award Optionscancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionscancelledInPeriodWeightedAverageExercisePrice
0
CY2022Q4 karx Share Exchange Agreement
ShareExchangeAgreement
0.80 pure
CY2022Q4 karx Share Exchange Agreement Value
ShareExchangeAgreementValue
3750000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
30000 usd
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
352948 usd
CY2022Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
176777 usd

Files In Submission

Name View Source Status
0001477932-23-000473-index-headers.html Edgar Link pending
0001477932-23-000473-index.html Edgar Link pending
0001477932-23-000473.txt Edgar Link pending
0001477932-23-000473-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
karx-20221130.xsd Edgar Link pending
karx_10q.htm Edgar Link pending
karx_ex311.htm Edgar Link pending
karx_ex312.htm Edgar Link pending
karx_ex321.htm Edgar Link pending
karx_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
karx-20221130_cal.xml Edgar Link unprocessable
karx-20221130_lab.xml Edgar Link unprocessable
karx-20221130_pre.xml Edgar Link unprocessable
karx_10q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
karx-20221130_def.xml Edgar Link unprocessable